| 4878 |
Centers for Disease Control and Prevention |
Html |
en |
Laboratory Detection of VISA/VRSA - HAI |
null |
| Clinical Microbiology | 0.428018 |
| glycopeptides | 0.43185 |
| oxacillin-resistant isolates | 0.670535 |
| important agent | 0.425033 |
| Slower growing cells | 0.525117 |
| antimicrobial agents | 0.646984 |
| Clinical Laboratory Standards. | 0.531973 |
| Vitek software | 0.426862 |
| S. epidermidis | 0.45952 |
| oxacillin-resistant CoNS | 0.524664 |
| single group | 0.438442 |
| term glycopeptide | 0.55447 |
| limits therapeutic options | 0.52436 |
| vancomycin MICs | 0.941659 |
| minimum inhibitory concentration | 0.537754 |
| S. McAllister | 0.429983 |
| Staphylococcus epidermidis | 0.440171 |
| S. haemolyticus | 0.533015 |
| Limited treatment options | 0.535066 |
| S. clinical trials | 0.568519 |
| decreased susceptibility | 0.784979 |
| Clinical Laboratory Standards | 0.727723 |
| hospital-acquired infections | 0.450867 |
| susceptibility test methods | 0.976905 |
| Reduced Susceptibility | 0.650154 |
|
| MicroScan rapid panels | 0.529938 |
| CoNS species | 0.559488 |
| therapeutic agents | 0.428191 |
| coagulase-negative staphylococci | 0.504446 |
| impaired host defenses | 0.556258 |
| infection control precautions | 0.533116 |
| commonly used susceptibility | 0.779578 |
| Yes. Staphylococci | 0.517635 |
| broader scope | 0.424819 |
| invasive devices | 0.435371 |
| antimicrobial susceptibility testing | 0.774268 |
| CoNS infection rate | 0.682577 |
| MicroScan conventional panels | 0.528428 |
| National Committee | 0.656785 |
| species level | 0.437345 |
| reduced susceptibilities | 0.425042 |
| clinical isolates | 0.693237 |
| clinical significance | 0.45635 |
| resistance trends | 0.429794 |
| routine susceptibility test | 0.759481 |
| treatment options | 0.536314 |
| New England Journal | 0.512618 |
| R.V. Spera | 0.422682 |
| vancomycin resistance | 0.760317 |
|
CLICK HERE |
| 7312 |
Centers for Disease Control and Prevention |
Html |
en |
MMWR News Synopsis: August 16, 2012 |
CDC Media Relations - MMWR News Synopsis: August 16, 2012 |
| gut motility | 0.497518 |
| overall varicella incidence | 0.731652 |
| public health authorities | 0.585086 |
| Clostridium perfringens | 0.571987 |
| hospital’s patients | 0.50476 |
| core recommendation | 0.484889 |
| National Center | 0.567852 |
| psychiatric hospitals | 0.493818 |
| psychiatric drugs | 0.496863 |
| new urgency | 0.499346 |
| routine varicella vaccination | 0.907012 |
| 2-dose varicella vaccination | 0.745328 |
| deaths | 0.46107 |
| varicella vaccine | 0.682373 |
| TB Prevention | 0.580461 |
| Advisory Committee | 0.483006 |
| United States | 0.718329 |
| patients | 0.50511 |
| Viral Hepatitis | 0.577341 |
| varicella incidence | 0.796477 |
| consistent varicella | 0.643373 |
| Routine annual vaccination | 0.607335 |
| 2010-2011 season | 0.483567 |
| foodborne illness | 0.681136 |
| National varicella surveillance | 0.71145 |
|
| 2012-2013 season | 0.482261 |
| 2-dose coverage increases | 0.554582 |
| severe disease | 0.489487 |
| vaccination coverage increases | 0.597878 |
| HUMAN SERVICES | 0.484146 |
| bacterial toxins | 0.495464 |
| vaccine formulations | 0.517585 |
| varicella surveillance | 0.720191 |
| same—routine annual vaccination | 0.588647 |
| age group | 0.486499 |
| News Media Line | 0.70273 |
| CDC
Division | 0.54224 |
| 2012-2013 influenza season | 0.549834 |
| Immunization Practices | 0.483929 |
| Louisiana psychiatric hospital | 0.592108 |
| varicella vaccination program | 0.898661 |
| U.S. DEPARTMENT | 0.48424 |
| food poisoning | 0.502562 |
| common side effect | 0.491979 |
| influenza vaccines | 0.48441 |
| Electronic Media | 0.502247 |
| greatest declines | 0.495508 |
| case-based varicella surveillance | 0.709136 |
| recent outbreak | 0.517616 |
|
CLICK HERE |
| 8959 |
Centers for Disease Control and Prevention |
Html |
en |
Selected Local Public Health Counsel Directory |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 9568 |
Centers for Disease Control and Prevention |
Html |
en |
Assessing the Risks for Poliovirus Outbreaks in Polio-FreeCountries - Africa, 2012-2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| risk assessments | 0.40896 |
| population immunity risk | 0.255111 |
| GPEI partners | 0.403444 |
| high-risk countries | 0.33964 |
| risk mitigation activities | 0.323637 |
| poliovirus transmission | 0.218242 |
| high-risk polio-free countries | 0.234078 |
| annual nonpolio AFP | 0.225654 |
| risk mitigation measures | 0.217939 |
| subnational areas | 0.216422 |
| high-risk subpopulations | 0.213879 |
| risk mitigation | 0.39645 |
| moderate-risk countries | 0.386857 |
| AFP cases | 0.229408 |
| AFP surveillance reviews | 0.265976 |
| population immunity indicator | 0.207993 |
| population immunity | 0.853829 |
| polio-free countries | 0.548499 |
|
| preventive SIAs | 0.388477 |
| AFP surveillance performance | 0.244144 |
| previously polio-free countries | 0.2286 |
| WPV importation belt | 0.781808 |
| active WPV transmission | 0.208327 |
| World Health Organization | 0.288954 |
| national AFP surveillance | 0.340556 |
| periodic preventive SIAs | 0.259677 |
| targeted subnational SIAs | 0.248431 |
| risk mitigation efforts | 0.217394 |
| WPV importation | 0.903406 |
| countries | 0.629189 |
| augment AFP surveillance | 0.242536 |
| West African WPV | 0.217546 |
| regional office | 0.231256 |
| WPV outbreaks | 0.334084 |
| limited AFP surveillance | 0.250744 |
| risk | 0.441567 |
|
CLICK HERE |
| 11106 |
Centers for Disease Control and Prevention |
Html |
en |
2008 National Report on Biochemical Indicators of Diet and Nutrition - Appendices |
null |
| dietary folate intake | 0.369749 |
| methylmalonic acid concentrations | 0.371648 |
| United States population | 0.389413 |
| Clin Nutr. | 0.501393 |
| Stat Series No. | 0.521106 |
| serum folate | 0.396179 |
| high serum concentrations | 0.380764 |
| serum selenium concentrations | 0.380419 |
| J. Elevated serum | 0.387145 |
| Nutrition Examination Survey | 0.912104 |
| sample size | 0.395355 |
| Pfeiffer CM | 0.466406 |
| Nutrition Examination Surveys | 0.456158 |
| National Center | 0.441676 |
| Expo Anal Environ | 0.392682 |
| Vital Health Stat | 0.565051 |
| SAS Proc Univariate | 0.41478 |
| Dietary intake | 0.393495 |
| various NHANES surveys | 0.369618 |
| National Health | 0.67249 |
| Health Statistics | 0.445417 |
| Wright JD | 0.370703 |
| Gunter EW | 0.725245 |
| Looker AC | 0.446481 |
| Bowman BA | 0.413673 |
|
| Anal Environ Epidemiol. | 0.393871 |
| folate status | 0.373402 |
| serum concentrations | 0.396479 |
| folic acid fortification | 0.402217 |
| serum retinol concentrations | 0.37971 |
| total homocysteine concentrations | 0.461955 |
| United States | 0.69907 |
| serum total homocysteine | 0.41503 |
| folate nutritional status | 0.37048 |
| Advance Data No. | 0.418808 |
| plasma total homocysteine | 0.406979 |
| serum ferritin values | 0.40146 |
| Caudill SP | 0.419263 |
| blood folate | 0.403626 |
| different population surveys | 0.375341 |
| serum methylmalonic acid | 0.386969 |
| States National Health | 0.383928 |
| U.S. population | 0.42432 |
| Clin Chem. | 0.466782 |
| Johnson CL | 0.467782 |
| et al | 0.445004 |
| percent confidence intervals | 0.372249 |
| confidence intervals | 0.382106 |
| serum | 0.422438 |
|
CLICK HERE |
| 11663 |
Centers for Disease Control and Prevention |
Html |
en |
Enterovirus D68 for Health Care Professionals |
Enterovirus D68 for Health Care Professionals. |
| Enterovirus D68 | 0.776694 |
| treatment | 0.333736 |
| general information | 0.505125 |
| EV-D68 testing | 0.499038 |
| overall effectiveness | 0.454478 |
| Asthma Care Quick | 0.667395 |
| Reinforce | 0.339232 |
| environmental disinfection specific | 0.609897 |
| alcohol-based hand rub | 0.609312 |
| enveloped viruses | 0.486345 |
| non-enveloped viruses | 0.468767 |
| EV-D68 infection | 0.580235 |
| summer | 0.333478 |
| local health department | 0.918095 |
| additional guidance | 0.471015 |
| oropharyngeal swabs | 0.501866 |
| state health departments | 0.636671 |
| local health departments | 0.634071 |
| specimen submission form | 0.620703 |
| respiratory specimens | 0.777928 |
| acute respiratory illness | 0.681624 |
| patient summary form | 0.612798 |
| risk factors | 0.496724 |
| skin tolerance | 0.463059 |
|
| non-polio enteroviruses | 0.561522 |
| vegetative bacteria | 0.472076 |
| adherence | 0.338124 |
| molecular typing | 0.664304 |
| patients | 0.364221 |
| wide variety | 0.46245 |
| diagnosis | 0.333762 |
| Overview | 0.333709 |
| asthma action plan | 0.675297 |
| CDC health | 0.592206 |
| Healthcare Settings | 0.461546 |
| rhinovirus | 0.330959 |
| specimen submission | 0.643017 |
| upper respiratory specimens | 0.757629 |
| symptoms | 0.333824 |
| infection control measures | 0.688851 |
| long-term control medication | 0.632659 |
| sera | 0.33482 |
| Contact your state | 0.628326 |
| healthcare pathogens | 0.462477 |
| hand hygiene | 0.591417 |
| possible cause | 0.49467 |
| Droplet Precautions | 0.508757 |
|
CLICK HERE |
| 11958 |
Centers for Disease Control and Prevention |
Html |
en |
Byanca's Story' Stories | LSHT | Campaigns | Act Against AIDS | CDC |
This is a story written by an individual living with HIV detailing her experience with the disease. |
| pills | 0.46391 |
| dad | 0.461935 |
| idea | 0.452965 |
| AIDS complications | 0.624876 |
| people | 0.494922 |
| life | 0.506646 |
| way | 0.495069 |
| mother | 0.522071 |
| condition | 0.450418 |
| world | 0.447592 |
|
| HIV | 0.947627 |
| Byanca | 0.462768 |
| innocent child | 0.601553 |
| grade | 0.456038 |
| Thanks | 0.455752 |
| time | 0.507848 |
| Camp Hope | 0.589325 |
| status | 0.495636 |
| parents | 0.494939 |
| kids | 0.450995 |
|
CLICK HERE |
| 15824 |
Centers for Disease Control and Prevention |
Html |
en |
Lab Quality Program Important to Newborn Screening | CDC Features |
Learn about one of the nation’s most successful public health programs for newborn screening – CDC’s National Center for Environmental Health (NCEH) Lab Quality Program. |
| Laboratory Sciences | 0.416597 |
| external check | 0.354116 |
| international laboratories | 0.364824 |
| timely intervention | 0.413306 |
| Assurance Program | 0.366778 |
| filter paper | 0.446727 |
| blood sample | 0.408446 |
| molecular marker | 0.404101 |
| state health departments | 0.409783 |
| filter paper cards | 0.400059 |
| National Center | 0.474698 |
| Molecular Biology Branch | 0.406832 |
| test results | 0.414466 |
| Environmental Health | 0.462189 |
| non-regulatory program | 0.361808 |
| CDC’s NSQAP | 0.36907 |
| severe disorders | 0.52423 |
| state laboratory | 0.402749 |
| early identification | 0.409351 |
| Mei | 0.375398 |
| important role | 0.363464 |
| CDC’s Division | 0.367375 |
| newborn children | 0.494879 |
| specially prepared cards | 0.399059 |
| quality assurance samples | 0.587136 |
|
| new disorder | 0.38797 |
| spot quality assurance | 0.488048 |
| early morning | 0.354213 |
| newborn screening | 0.961896 |
| baby’s heel | 0.415035 |
| Newborn Screening Quality | 0.582491 |
| newborn screening labs | 0.553172 |
| appropriate dried blood | 0.402155 |
| life-saving treatments | 0.418382 |
| newborn screening disorder | 0.622631 |
| new screening tests | 0.44538 |
| blood spot quality | 0.484357 |
| different biochemical markers | 0.404683 |
| specific molecular markers | 0.401653 |
| newborn screening test | 0.579498 |
| Joanne Mei | 0.374199 |
| blood spots | 0.403944 |
| Health Lab Quality | 0.426059 |
| newborn screening laboratories | 0.543854 |
| labs test | 0.354326 |
| blinded samples | 0.356486 |
| public health programs | 0.615364 |
| CDC team provide | 0.40189 |
| program’s role | 0.356183 |
|
CLICK HERE |
| 16200 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Regional Measles Elimination - Worldwide,2000-2015 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| supplementary immunization activities | 0.526707 |
| Measles Nucleotide Surveillance | 0.672386 |
| global measles control | 0.660455 |
| United Nations | 0.511648 |
| endemic measles virus | 0.634994 |
| persistent measles | 0.617851 |
| annual estimated measles | 0.670982 |
| highest measles mortality | 0.63347 |
| measles incidence | 0.717287 |
| measles vaccination coverage | 0.743594 |
| MCV1 coverage | 0.524224 |
| measles elimination goals | 0.763005 |
| measles elimination efforts | 0.681328 |
| measles mortality | 0.709974 |
| measles virus | 0.760068 |
| routine immunization services | 0.668229 |
| regional verification commission | 0.527169 |
| national immunization coverage | 0.523188 |
| measles control | 0.72631 |
| measles virus genotypes | 0.69074 |
| endemic measles | 0.705992 |
| measles susceptibility | 0.631176 |
| countries | 0.627083 |
| measles vaccination | 0.813137 |
|
| new measles vaccination | 0.655418 |
| epidemiologically confirmed measles | 0.622654 |
| annual measles | 0.688757 |
| measles surveillance activities | 0.636496 |
| measles disease | 0.618119 |
| measles surveillance | 0.647322 |
| regional measles elimination | 0.73157 |
| global measles | 0.712712 |
| global measles mortality | 0.6834 |
| measles cases | 0.851072 |
| measles SIAs | 0.621696 |
| detectable measles | 0.600911 |
| measles vaccine | 0.621269 |
| annual measles incidence | 0.680139 |
| measles virus sequences | 0.636433 |
| case-based measles surveillance | 0.627862 |
| endemic measles transmission | 0.649926 |
| compatible measles cases | 0.634373 |
| measles deaths | 0.65181 |
| measles virus genome | 0.665 |
| measles cases** | 0.6239 |
| measles-containing vaccine | 0.53036 |
| follow-up sias | 0.507013 |
| Global Vaccine Action | 0.503626 |
|
CLICK HERE |
| 16378 |
Centers for Disease Control and Prevention |
Html |
en |
Zika Pregnancy and Birth Defects Local Health Department Field Support |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| specific birth defects | 0.43193 |
| pregnancies | 0.230154 |
| Centers | 0.221769 |
| LHD initiative | 0.386396 |
| infant outcomes | 0.330695 |
| Collect | 0.222502 |
| purpose | 0.221264 |
| CDC Zika Local | 0.510965 |
| questions | 0.222098 |
| Zika virus infection | 0.658489 |
| health department requests | 0.431747 |
| following areas | 0.318646 |
| local health department | 0.985418 |
| duration | 0.225994 |
| Prevention | 0.221722 |
| possible Zika virus | 0.646927 |
| pregnant women | 0.461482 |
| Help pregnant women | 0.437392 |
| Disease Control | 0.331548 |
| children | 0.220373 |
| technical assistance | 0.316514 |
| contact | 0.222032 |
|
| CDC personnel | 0.344233 |
| local health departments | 0.42975 |
| infants | 0.249892 |
| agreement | 0.221147 |
| laboratory evidence | 0.449886 |
| supplemental field support | 0.446962 |
| assignment | 0.224187 |
| contract period | 0.320281 |
| services | 0.22029 |
| families | 0.220345 |
| health department capacity | 0.446103 |
| trained personnel | 0.319429 |
| CDC-contracted support | 0.320634 |
| primary target | 0.31745 |
| field support | 0.685398 |
| application | 0.243019 |
| exposure | 0.220923 |
| cdc.gov | 0.221984 |
| complete data | 0.32632 |
| local health departments1 | 0.456671 |
| national organizations | 0.318699 |
| applications | 0.221675 |
|
CLICK HERE |